This paper explores the transformative shift in drug discovery from traditional animal-based modeling toward human-centric New Approach Methodologies (NAMs). This evolution is driven by high clinical failure rates and is supported by updated regulatory frameworks from the FDA and NIH that no longer mandate animal testing. The review categorizes these innovations into stem cell-based, organoid-base...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
